Építés alatt – nem éles oldal
Belépés
BefejeződöttFázis nélkül

Investigating Mild Cognitive Impairment in Patients And Controls With TD-fNIRS

A legfontosabb adatok

Ki végzi
Kernel
Hol
Carlsbad, Costa Mesa, Escondido, Los Angeles, Santa Ana és Temecula (Egyesült Államok)Mind a 6 helyszín megnézése
Azonosító
Állapot
Befejeződött
Résztvevők
133 fő vett részt
Kezdés
2023. júl. 25.
Befejezés
2024. jún. 13.
A vizsgálat típusa
Megfigyeléses, 2 csoport
A vizsgált kezelések
  • fNIRS measurement
A regiszteradat frissítve
2024. július 3.

Ki vehet részt

Életkor
55 év – 85 év
Nem
Nők és férfiak
Egészséges önkéntesek
Részt vehetnek
A regiszter összes feltétele (21)A regiszter feltételeinek elrejtése

Ki vehet részt

  • Patients
  • Must have a diagnosis of MCI (amnesiac or non-amnesiac) as determined by clinician
  • Adults (older adults) between the ages of 55-85 years inclusive at time of enrollment
  • Ability to perform informed consent on their own
  • Fluent in English (speaking and reading); Healthy Controls
  • Adults (older adults) between the ages of 55-85 years inclusive at time of enrollment
  • Ability to perform informed consent on their own
  • Fluent in English (speaking and reading)

Ki nem vehet részt

  • Current substance or alcohol dependence, and/or alcohol or substance abuse as determined by CAGE-AID assessment for drug and alcohol abuse. A score of 2 or higher would result in exclusion
  • Prior MCI or memory impairment diagnosis
  • Current substance or alcohol dependence, and/or alcohol or substance abuse as determined by CAGE-AID assessment for drug and alcohol abuse. A score of 2 or higher would result in exclusion
  • Alzheimer's or dementia diagnosis
  • Current or recent (in the past 6 months) chemotherapy and/or radiation for any cancer
  • Major medical illnesses and psychiatric conditions (other than MCI) including:; Severe/uncontrolled Diabetes, hypertension and hypothyroidism that could pose secondary causes of cognitive decline; Parkinson's disease; Motor neuron diseases; Multiple Sclerosis; Brain Tumor; Stroke; Encephalitis; Meningitis; Epilepsy; TBI with serious results (coma, unconscious for >2 hrs, or skull fracture); Current serious psychiatric conditions (bipolar disorder, schizophrenia, or psychosis); Healthy Controls
  • First-degree relative with dementia or clinically relevant memory problems
  • Alzheimer's or dementia diagnosis
  • Current or recent (in the past 6 months) chemotherapy and/or radiation for any cancer
  • Major medical illnesses and psychiatric conditions including:; Severe/uncontrolled Diabetes, hypertension and hypothyroidism that could pose secondary causes of cognitive decline; Parkinson's disease; Motor neuron diseases; Multiple Sclerosis; Brain Tumor; Stroke; Encephalitis; Meningitis; Epilepsy; TBI with serious results (coma, unconscious for >2 hrs, or skull fracture); Current serious psychiatric conditions (bipolar disorder, schizophrenia, or psychosis)
  • Patients
  • Has uncorrected major visual or auditory deficits that would prevent them from completing a study task
  • Has uncorrected major visual or auditory deficits that would prevent them from completing a study task

Helyszínek itt: Egyesült Államok

  • The Research Center of Southern CaliforniaCarlsbad, Egyesült Államok
  • BrainHealth SolutionsCosta Mesa, Egyesült Államok
  • The Research Center of Southern CaliforniaEscondido, Egyesült Államok
  • KernelLos Angeles, Egyesült Államok
  • Syrentis Clinical ResearchSanta Ana, Egyesült Államok
  • The Research Center of Southern CaliforniaTemecula, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

The goal of the proposed observational, multi-site study is to use fNIRS neurophysiological data recorded during a battery of tasks to detect MCI within a cohort consisting of patients and age-matched healthy controls. Furthermore, the investigators aim to explore whether they can measure the severity of MCI symptoms in the patient population. If successful, this approach enables clinicians to track the disease at its source-the brain; possibly allowing for earlier detection of MCI and its progression, and ultimately more efficient interventions.

A vizsgálat 2 csoportja

  • MCI Patients

    Adult participants who are seeking neurological assessments for Mild Cognitive Impairment (MCI) at a participating clinic/study site.

    Kezelés: fNIRS measurement

  • Healthy Controls

    Healthy participants without a prior MCI or memory impairment diagnosis.

    Kezelés: fNIRS measurement

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
IMPACT: Investigating Mild Cognitive Impairment in Patients And Controls With TD-fNIRS
A regiszteradat frissítve
2024. július 3.